<DOC>
	<DOCNO>NCT02663102</DOCNO>
	<brief_summary>The purpose study collect safety information use Fluarix Tetra accord approve PI , period 6 year child ( 3 year age ) adult Korea .</brief_summary>
	<brief_title>Evaluation Safety GlaxoSmithKline ( GSK ) Vaccines ' Quadrivalent Seasonal Influenza Vaccine , Fluarix Tetra When Administered According Approved Prescribing Information ( PI ) Korea .</brief_title>
	<detailed_description>Adults previously vaccinate child age â‰¥36 month , single dose Fluarix Tetra administer . To previously unvaccinated child age 36 month &lt; 9 year , two dos administer second dose least 4 week apart first one per local PI Korea . Fluarix Tetra may administer pregnant women/lactating woman per PI , clear need . Pregnancy outcome ( whether full-term premature , information status mother child ) vaccinate pregnant subject followed-up 6-8 week delivery , possible .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Tetracycline</mesh_term>
	<criteria>Male female subject vaccinate Fluarix Tetra eligible receive Fluarix Tetra accord locally approve PI . Signed informed consent Informed Consent Form ( ICF ) /Informed Assent Form ( IAF ) obtain subject/subject 's parent ( ) /Legally acceptable Representative ( ) [ LAR ( ) ] . Those eligible vaccination Fluarix Tetra accord local PI . Hypersensitivity reaction Fluarix Tetra . History hypersensitivity reaction Influenza vaccine . History GuillainBarre syndrome nervous system abnormality Influenza vaccine within 6 week postvaccination . Those eligible vaccination Fluarix Tetra accord medical judgement physician .</criteria>
	<gender>All</gender>
	<minimum_age>36 Months</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Safety</keyword>
	<keyword>Post-marketing</keyword>
	<keyword>Korea</keyword>
	<keyword>Drug utilization study</keyword>
	<keyword>Fluarix Tetra</keyword>
</DOC>